Novel Processed Form of Syndecan-1 Shed from SCC-9 Cells Plays a Role in Cell Migration

被引:41
|
作者
Aragao, Annelize Z. B. [1 ]
Belloni, Marilia [1 ]
Simabuco, Fernando M. [1 ]
Zanetti, Mariana R. [1 ]
Yokoo, Sami [1 ]
Domingues, Romenia R. [1 ]
Kawahara, Rebeca [1 ]
Pauletti, Bianca A. [1 ]
Goncalves, Anderson [1 ]
Agostini, Michelle [2 ]
Graner, Edgard [2 ]
Coletta, Ricardo D. [2 ]
Fox, Jay W. [3 ]
Paes Leme, Adriana F. [1 ]
机构
[1] Brazilian Biosci Natl Lab CNPEM, Mass Spectrometry Lab, Campinas, SP, Brazil
[2] Univ Estadual Campinas, Piracicaba Sch Dent, Piracicaba, Brazil
[3] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA
来源
PLOS ONE | 2012年 / 7卷 / 08期
关键词
PROTEOMIC ANALYSIS; INTRACELLULAR DOMAIN; CLEAVAGE; EXPRESSION; REDUCTION; CARCINOMA; RELEASE;
D O I
10.1371/journal.pone.0043521
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The extracellular milieu is comprised in part by products of cellular secretion and cell surface shedding. The presence of such molecules of the sheddome and secretome in the context of the extracellular milieu may have important clinical implications. In cancer they have been hypothesized to play a role in tumor growth and metastasis. The objective of this study was to evaluate whether the sheddome/secretome from two cell lines could be correlated with their potential for tumor development. Two epithelial cell lines, HaCaT and SCC-9, were chosen based on their differing abilities to form tumors in animal models of tumorigenesis. These cell lines when stimulated with phorbol-ester (PMA) showed different characteristics as assessed by cell migration, adhesion and higher gelatinase activity. Proteomic analysis of the media from these treated cells identified interesting, functionally relevant differences in their sheddome/secretome. Among the shed proteins, soluble syndecan-1 was found only in media from stimulated tumorigenic cells (SCC-9) and its fragments were observed in higher amount in the stimulated tumorigenic cells than stimulated non-tumorigenic cells (HaCaT). The increase in soluble syndecan-1 was associated with a decrease in membrane-bound syndecan-1 of SCC-9 cells after PMA stimuli. To support a functional role for soluble syndecan-1 fragments we demonstrated that the synthetic syndecan-1 peptide was able to induce cell migration in both cell lines. Taken together, these results suggested that PMA stimulation alters the sheddome/secretome of the tumorigenic cell line SCC-9 and one such component, the syndecan-1 peptide identified in this study, was revealed to promote migration in these epithelial cell lines.
引用
收藏
页数:12
相关论文
共 45 条
  • [41] Activation of FKHRL1 plays an important role in protecting erythroid cells from erythropoietin deprivation-induced apoptosis in a human erythropoietin-dependent leukemia cell line, UT-7/EPO
    Uchida, Mie
    Kirito, Keita
    Endo, Hitoshi
    Ozawa, Keiya
    Komatsu, Norio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 86 (04) : 315 - 324
  • [42] Activation of FKHRL1 Plays an Important Role in Protecting Erythroid Cells from Erythropoietin Deprivation-Induced Apoptosis in a Human Erythropoietin-Dependent Leukemia Cell Line, UT-7/EPO
    Mie Uchida
    Keita Kirito
    Hitoshi Endo
    Keiya Ozawa
    Norio Komatsu
    International Journal of Hematology, 2007, 86 : 315 - 324
  • [43] A NOVEL ROLE FOR THE NOTCH SIGNALLING PATHWAY IN KELOID DISEASE: FIRST DEMONSTRATION OF ENHANCED CELL PROLIFERATION, MIGRATION, ANGIOGENESIS AND CELL INVASION IN A JAGGED-1 PEPTIDE DEPENDENT MANNER IN NORMAL SKIN FIBROBLASTS ISOLATED FROM KELOID PATIENTS
    Syed, F.
    Kolluru, V.
    Iqbal, S. A.
    Singh, S.
    Bayat, A.
    WOUND REPAIR AND REGENERATION, 2011, 19 (02) : A55 - A55
  • [44] Myeloid cell leukaemia 1 has a vital role in retinoic acid-mediated protection of Toll-like receptor 9-stimulated B cells from spontaneous and DNA damage-induced apoptosis
    Holm, Kristine L.
    Indrevaer, Randi L.
    Myklebust, June Helen
    Kolstad, Arne
    Moskaug, Jan Oivind
    Naderi, Elin H.
    Blomhoff, Heidi K.
    IMMUNOLOGY, 2016, 149 (01) : 62 - 73
  • [45] Results from a First-in-Human Study with Bnz-1: A Novel Peptide Inhibitor of IL-2, IL9 and IL-15 for the Treatment of T-Cell Malignancies That Safely and Selectively Decreases Regulatory T-Cells, Natural Killer Cells, and CD8+ Central Memory T-Cells
    Frohna, Paul
    Tagaya, Yutaka
    Ratnayake, Anoshie
    Doerr, Nick
    Basheer, Asjad
    Al-Mawsawi, Laith
    Kim, Woo Jae
    Zapata, Juan
    Wu, Xisorong
    Azimi, Nazli
    BLOOD, 2017, 130